Balance Sheet
Accounts PayablesAssetsBuildingsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Borealis Foods (BRLS) Other Accumulated Expenses (2021 - 2025)

Borealis Foods has reported Other Accumulated Expenses over the past 4 years, most recently at $19.1 million for Q3 2025.

  • For Q3 2025, Other Accumulated Expenses rose 24.03% year-over-year to $19.1 million; the TTM value through Sep 2025 reached $19.1 million, up 24.03%, while the annual FY2024 figure was $15.4 million, 97.14% up from the prior year.
  • Other Accumulated Expenses for Q3 2025 was $19.1 million at Borealis Foods, up from $18.9 million in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $19.1 million in Q3 2025 and troughed at $58640.0 in Q3 2023.
  • A 4-year average of $11.6 million and a median of $15.4 million in 2024 define the central range for Other Accumulated Expenses.
  • Biggest five-year swings in Other Accumulated Expenses: soared 26208.75% in 2024 and later rose 22.21% in 2025.
  • Year by year, Other Accumulated Expenses stood at $158640.0 in 2022, then soared by 4833.05% to $7.8 million in 2023, then soared by 97.14% to $15.4 million in 2024, then grew by 24.03% to $19.1 million in 2025.
  • Business Quant data shows Other Accumulated Expenses for BRLS at $19.1 million in Q3 2025, $18.9 million in Q2 2025, and $16.5 million in Q1 2025.